期刊
BIOMEDICINES
卷 11, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines11082192
关键词
antiphospholipid syndrome; criteria; non-criteria; antiphospholipid antibodies; correlation
This research aimed to evaluate the correlations between the titres of non-criteria aPLs and the already studied criteria aPLs in APS patients. The results showed moderate correlations mainly between the tested non-criteria antibodies and the criteria ones, suggesting little added value for the use of the tested non-criteria aPLs.
The place of non-criteria antiphospholipid antibodies (aPLs) in the diagnosis of antiphospholipid syndrome (APS) is still debatable. The aim of this research was to evaluate the correlations between the titres of non-criteria aPLs (anti-phosphatidylethanolamine (aPE), anti-phosphatidylserine (aPS), and anti-prothrombin (aPT) antibodies), and the ones of the already studied criteria aPLs (anticardiolipin (aCL) and anti-fi2 glycoprotein I-afi2GPI antibodies). Altogether, 72 APS (30 primary and 42 secondary) patients were included in our study. High correlation coefficients (rs) were found between aPS IgM and aCL IgM, overall (0.77, p < 0.01), as well as in the primary (0.81, p < 0.01), and secondary (0.75, p < 0.01) APS subgroups. Low or statistically insignificant correlations were observed between IgG/IgM isotypes of aPT and aCL, or a fi2GPI, in the entire study population, and when evaluating the subgroups. Therefore, moderate correlations were mainly identified between the tested non-criteria antibodies and the criteria ones, suggesting little added value for the use of the tested non-criteria aPLs, with the exception of aPT, which seems to have different kinetics and might be a promising APS diagnostic tool.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据